Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.00
+0.14 (1.42%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $1.34 billion as of March 9, 2026. Its market cap has increased by 144.18% in one year.
Market Cap
1.34B
Enterprise Value
952.85M
1-Year Change
144.18%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.34B, an increase of 677.18%. That is a compound annual growth rate of 32.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.34B | -4.76% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.41B |
| Zenas BioPharma | 1.40B |
| Monte Rosa Therapeutics | 1.40B |
| Savara | 1.34B |
| Corvus Pharmaceuticals | 1.33B |
| MBX Biosciences | 1.32B |
| MoonLake Immunotherapeutics | 1.31B |
| EyePoint | 1.31B |